Inventor · disambiguated record
Richard Theolis
Also filed as: THEOLIS RICHARD · THÉOLIS JR RICHARD
14 granted patents·10 pending applications·89 citations·filing 2007–2025
92Inventor score
Files withCOMPUGEN LTD13DENALI THERAPEUTICS INC2KENJOCKETY BIOTECHNOLOGY INC2SQUIBB & SONS LLC2UNITY BIOTECHNOLOGY INC2
Top patents by PatentIndex Score
24 records- 0195US12312404B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2023·Granted May 27, 2025·1 cites·16 claims
- 0294US11623955B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Apr 11, 2023·3 cites·33 claims
- 0394US9714289B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jul 25, 2017·14 cites·20 claims
- 0493US10124061B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Nov 13, 2018·9 cites·20 claims
- 0592US10751415B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Aug 25, 2020·6 cites·22 claims
- 0692US10213505B2Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2018·Granted Feb 26, 2019·6 cites·2 claims
- 0791US11220542B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jan 11, 2022·3 cites·42 claims
- 0890US10227408B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Mar 12, 2019·6 cites·20 claims
- 0990US8481683B2Human antibodies that bind CD22 and uses thereofKING DAVID JOHN·Filed 2007·Granted Jul 9, 2013·31 cites·20 claims
- 1086US9499632B2Human antibodies that bind CD22 and uses thereofSQUIBB & SONS LLC·Filed 2013·Granted Nov 22, 2016·8 cites·42 claims
- 1184US2025333503A1Anti-pvrig antibodies and methods of useCOMPUGEN LTD·Filed 2025·Application pending·0 cites
- 1283US11701424B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2020·Granted Jul 18, 2023·1 cites·30 claims
- 1379US2024139318A1Anti-tigit antibodies, anti-pvrig antibodies and combinations thereofCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1477US12195542B2Antibodies directed to Tie-2 and methods of useUNITY BIOTECHNOLOGY INC·Filed 2020·Granted Jan 14, 2025·1 cites·18 claims
- 1575US11795220B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·24 claims
- 1668US10351625B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2018·Granted Jul 16, 2019·0 cites·34 claims
- 1761US2024392012A1Antibodies Directed to TIE-2 and Methods of UseUNITY BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 1855US2025136713A1Anti-her2 antibodies and methods of use thereofDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1955US2024392035A1Engineered anti-her2 bispecific proteinsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2050US2017058031A1Human antibodies that bind cd22 and uses thereofSQUIBB & SONS LLC·Filed 2016·Application pending·0 cites
- 2147US2023272117A1Anti abcc1 antibodies and uses thereofKENJOCKETY BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2246US2023212305A1Anti-abcg2 antibodies and uses thereofKENJOCKETY BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2345US2011182904A1Antibodies to bone morphogenic proteins and receptors therefor and methods for their useZIMMERMAN DEBORAH·Filed 2007·Application pending·0 cites
- 2435US2019352426A1Plazomicin antibodies and methods of useACHAOGEN INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Theolis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →